{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T06:39:56Z","timestamp":1789540796340,"version":"build-2803163510"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,5,27]],"date-time":"2014-05-27T00:00:00Z","timestamp":1401148800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1007\/s12020-014-0290-2","type":"journal-article","created":{"date-parts":[[2014,5,26]],"date-time":"2014-05-26T03:27:34Z","timestamp":1401074854000},"page":"272-278","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["The effect of oral contraceptive different patterns of use on circulating IGF-1 and bone mineral density in healthy premenopausal women"],"prefix":"10.1007","volume":"48","author":[{"given":"Amany Y.","family":"Elkazaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled","family":"Salama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,5,27]]},"reference":[{"key":"290_CR1","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1089\/rej.2007.0597","volume":"10","author":"G Goldspink","year":"2007","unstructured":"G. Goldspink, Loss of muscle strength during aging studied at the gene level. Rejuvenation Res. 10, 397\u2013405 (2007)","journal-title":"Rejuvenation Res."},{"key":"290_CR2","doi-asserted-by":"crossref","first-page":"663","DOI":"10.2174\/138161207780249146","volume":"13","author":"L Laviola","year":"2007","unstructured":"L. Laviola, A. Natalicchio, F. Giorgino, The IGF-1 signaling pathway. Curr. Pharm. Des. 13, 663\u2013669 (2007)","journal-title":"Curr. Pharm. Des."},{"key":"290_CR3","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1210\/er.2007-0036","volume":"29","author":"G Giustina","year":"2008","unstructured":"G. Giustina, E. Mazziotti, Canalis, growth hormone, insulin-like growth factors, and the skeleton. Endocr. Rev. 29, 535\u2013559 (2008)","journal-title":"Endocr. Rev."},{"key":"290_CR4","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00198-007-0440-y","volume":"19","author":"H Zhao","year":"2008","unstructured":"H. Zhao, J. Liu, G. Ming, Y. Zhao, Y. Chen, L. Sun, L. Zhang, M. Xu, J. Chen, Relationships between insulin-like growth factor-1 (IGF-1) and OPG, RANKL, bone mineral density in healthy Chinese women. Osteoporos. Int. 19, 221\u2013226 (2008)","journal-title":"Osteoporos. Int."},{"key":"290_CR5","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/00008469-200110000-00008","volume":"10","author":"A Lukanova","year":"2001","unstructured":"A. Lukanova, P. Toniolo, A. Akhmedkhanov, K. Hunt, S. Rinaldi, A. Zeleniuch-Jacquotte, N.J. Haley, E. Riboli, P. Stattin, E. Lundin, R. Kaaks, A cross sectional study of IGF-1 determinants in women. Eur. J. Cancer Prev. 10, 443\u2013452 (2001)","journal-title":"Eur. J. Cancer Prev."},{"key":"290_CR6","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1677\/ERC-06-0080","volume":"14","author":"ES Schernhammer","year":"2007","unstructured":"E.S. Schernhammer, S. Tworoger, A. Eliassen, S.A. Missmer, J.M. Holly, M.N. Pollak, S.E. Hankinson, Body shape throughout life and correlation with IGFs and GH. Endocr. Relat. Cancer 14, 721\u2013732 (2007)","journal-title":"Endocr. Relat. Cancer"},{"key":"290_CR7","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1023\/A:1022518321634","volume":"14","author":"NE Allen","year":"2003","unstructured":"N.E. Allen, P.N. Appleby, R. Kaaks, S. Rinaldi, G.K. Davey, T.J. Key, Lifestyle determinants of serum insulin-like growth factor-1, C-peptide and hormone binding protein levels in British women. Cancer Causes Control 14, 65\u201374 (2003)","journal-title":"Cancer Causes Control"},{"key":"290_CR8","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1158\/1055-9965.EPI-04-0944","volume":"14","author":"SP Pinheiro","year":"2005","unstructured":"S.P. Pinheiro, M.D. Holmes, M.N. Pollak, R.L. Barbieri, S.E. Hankinson, Racial differences in premenopausal endogenous hormones. Cancer Epidemiol. Biomark. Prev. 14, 2147\u20132153 (2005)","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"290_CR9","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1385\/JCD:7:1:51","volume":"7","author":"AA Khan","year":"2004","unstructured":"A.A. Khan, L. Bachrach, J.P. Brown, D.A. Hanley, R.G. Josse, D.L. Kendler, E.S. Leib, B.C. Lentle, W.D. Leslie, E.M. Lewiecki, P.D. Miller, R.L. Nicholson, C. O\u2019Brien, W.P. Olszynski, M.Y. Theriault, N.B. Watts, Canadian Panel of the International Society of Clinical Densitometry. Standards and guidelines for performing central dual-energy X-ray absorptiometry in premenopausal women, men and children. J. Clin. Donsitom. 7, 51\u201364 (2004)","journal-title":"J. Clin. Donsitom."},{"key":"290_CR10","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/jbmr.5650090802","volume":"9","author":"JA Kanis","year":"1994","unstructured":"J.A. Kanis, L.J. Melton III, C. Christansen, C.C. Johanston, N. Khalitaev, The diagnosis of opsteoprosis. J. Bone Miner. Res. 9, 1137\u20131141 (1994)","journal-title":"J. Bone Miner. Res."},{"key":"290_CR11","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/PL00004148","volume":"7","author":"B Gullburg","year":"1997","unstructured":"B. Gullburg, O. Johnell, J.A. Kanis, World-wide projections of hip fracture. Osteoporos. Int. 7, 407\u2013413 (1997)","journal-title":"Osteoporos. Int."},{"key":"290_CR12","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1093\/oxfordjournals.epirev.a036126","volume":"15","author":"MR Sowers","year":"1993","unstructured":"M.R. Sowers, D.A. Galuska, Epidemiology of bone mass in premenopausal women. Epidemiol. Rev. 15, 374\u2013398 (1993)","journal-title":"Epidemiol. Rev."},{"key":"290_CR13","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.298.6678.924","volume":"298","author":"JC Stevenson","year":"1989","unstructured":"J.C. Stevenson, B. Less, M. Devenport, M.P. Cust, K.F. Ganger, Determinants of bone density in normal women: risk factors for future osteoporosis? Br. Med. J. 298, 924\u2013928 (1989)","journal-title":"Br. Med. J."},{"key":"290_CR14","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2165\/00024677-200403030-00006","volume":"3","author":"M Gambacciani","year":"2004","unstructured":"M. Gambacciani, P. Monteleone, M. Ciaponi, A. Sacco, A.R. Genazzani, Effects of oral Contraceptives on bone mineral density. Treat Endocrinol. 3, 191\u2013196 (2004)","journal-title":"Treat Endocrinol."},{"key":"290_CR15","first-page":"12","volume":"11","author":"S Sultana","year":"2002","unstructured":"S. Sultana, S. Choudhury, Effect of combined oral contraceptives on bone mineral density in pre and postmenopausal women. Mymensingh Med. J. 11, 12\u201314 (2002)","journal-title":"Mymensingh Med. J."},{"key":"290_CR16","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0002-9378(00)70209-2","volume":"182","author":"JA Pasco","year":"2000","unstructured":"J.A. Pasco, M.A. Kotowicz, M.J. Henry, S. Panahi, E. Seeman, G.C. Nicholson, Oral Contraceptives and bone mineral density: a population based study. Am. J. Obstet. Gynecol. 182, 265\u2013269 (2000)","journal-title":"Am. J. Obstet. Gynecol."},{"key":"290_CR17","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0010-7824(03)00147-1","volume":"68","author":"SD Reed","year":"2003","unstructured":"S.D. Reed, D. Schools, A.Z. LaCroix, L.E. Ichikawa, W.E. Bariow, S.M. Ott, Longitudinal changes in bone density in relation to oral contraceptive use. Contraception 68, 177\u2013182 (2003)","journal-title":"Contraception"},{"key":"290_CR18","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0010-7824(02)00308-6","volume":"65","author":"P Wanichsetakul","year":"2002","unstructured":"P. Wanichsetakul, A. Kamudhamas, P. Watanaruangkovit, Y. Siripakarn, P. Visutakul, Bone mineral density at various anatomic bone sites in women receiving combined oral contraceptives and depot-medroxyprogesterone acetate for contraception. Contraception 65, 407\u2013410 (2002)","journal-title":"Contraception"},{"key":"290_CR19","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0010-7824(00)00086-X","volume":"61","author":"W Kuohung","year":"2000","unstructured":"W. Kuohung, L. Borgatta, P. Stubblefield, Low-dose oral contraceptives and bone density: an evidence-based analysis. Contraception 61, 77\u201382 (2000)","journal-title":"Contraception"},{"key":"290_CR20","first-page":"1023","volume":"165","author":"JC Prior","year":"2001","unstructured":"J.C. Prior, S.A. Kirkland, L. Joseph, N. Kreiger, T.M. Murray, D.A. Hanley, J.D. Adachi, Y.M. Vigna, C. Berger, L. Blondeau, S.A. Jackson, A. Tenenhouse, Oral contraceptives use and bone mineral density in pre-menopausal women: cross-sectional, population-based data from the Canadian Multicentre Osteoporosis Study. Can. Med. Assoc. J. 165, 1023\u20131029 (2001)","journal-title":"Can. Med. Assoc. J."},{"key":"290_CR21","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/BF02556372","volume":"48","author":"K Laitinen","year":"1991","unstructured":"K. Laitinen, M. V\u00e4lim\u00e4ki, P. Keto, Bone mineral density measured by dual-energy X-ray absorptiometry in healthy Finish women. Calcit Tissue Int. 48, 224\u2013231 (1991)","journal-title":"Calcit Tissue Int."},{"key":"290_CR22","first-page":"2073","volume":"60","author":"S Cereh-Suhl","year":"1999","unstructured":"S. Cereh-Suhl, B.F. Yeager, Update on oral contraceptive pills. Am. Fam. Physician 60, 2073\u20132084 (1999)","journal-title":"Am. Fam. Physician"},{"key":"290_CR23","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1472-6874-11-15","volume":"11","author":"KM Blackmore","year":"2011","unstructured":"K.M. Blackmore, J. Wong, J.A. Knight, A cross-sectional study of different patterns of oral contraceptive use among premenopausal women and circulating IGF-1: implications for disease risk. BMC Women Health 11, 15\u201324 (2011)","journal-title":"BMC Women Health"},{"key":"290_CR24","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0010-7824(00)00176-1","volume":"62","author":"A Balogh","year":"2000","unstructured":"A. Balogh, E. Kauf, R. Vollanth, G. Grase, G. Klinger, M. Oettel, Effects of two oral contraceptives on plasma levels of insulin-like growth factor-1 (IGF-1) and growth hormone (hGH). Contraception 62, 259\u2013269 (2000)","journal-title":"Contraception"},{"key":"290_CR25","first-page":"377","volume":"10","author":"H Jernstrom","year":"2001","unstructured":"H. Jernstrom, C. Deal, F. Wilkin, W. Chu, Y. Tao, N. Majeed, T. Hudson, S.A. Narod, M. Pollak, Genetic and nongenetic factors associated with variation of plasma levels of Insulin like growth factor-1 and Insulin-like growth factor-binding protien-3 in healthy premenopausal women. Cancer Epidemiol. Biomark. Prev. 10, 377\u2013384 (2001)","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"290_CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0083-6729(08)60444-6","volume":"47","author":"MM Rechler","year":"1993","unstructured":"M.M. Rechler, Insulin-like growth factor binding proteins. Vitam. Horm. 47, 1\u2013114 (1993)","journal-title":"Vitam. Horm."},{"key":"290_CR27","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1001\/archinte.1991.00400100053009","volume":"151","author":"M Kleerekoper","year":"1991","unstructured":"M. Kleerekoper, R.S. Brienza, L.R. Schltz, C.C. Johnson, Oral contraceptive use may protect against low bone mass. Henry Ford Hospital Osteoporosis Cooperative Research Group. Arch. Intern. Med. 151, 1971\u20131976 (1991)","journal-title":"Arch. Intern. Med."},{"key":"290_CR28","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1472-6874-9-31","volume":"9","author":"F Allali","year":"2009","unstructured":"F. Allali, L. El Mansouri, F.Z. Abourazzak, L. Ichchou, H. Khazzani, L. Bennani, R. Abouqal, N.H. Hassouni, The effect of past use of oral contraceptive on bone mineral density, bone biochemical markers and muscle strength in healthy pre and post-menopausal women. BMC Women Health 9, 31\u201337 (2009)","journal-title":"BMC Women Health"},{"key":"290_CR29","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/S0029-7844(00)00782-1","volume":"95","author":"DB Petitti","year":"2000","unstructured":"D.B. Petitti, G. Piaggio, S. Mehta, M.C. Cravioto, O. Meirik, Steroid hormone contraception and bone mineral density: a cross-sectional study in an international population. The WHO Study of Hormonal Contraception and Bone Health. Obstet. Gynecol. 95, 736\u2013744 (2000)","journal-title":"Obstet. Gynecol."},{"key":"290_CR30","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/S0140-6736(98)09044-8","volume":"353","author":"K Micha\u00eblsson","year":"1999","unstructured":"K. Micha\u00eblsson, J.A. Baron, B.Y. Farahmand, I. Persson, S. Ljunghall, Oral contraceptive use and risk of hip fracture: a case-control study. The Lancet 353, 1481\u20131484 (1999)","journal-title":"The Lancet"},{"key":"290_CR31","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1056\/NEJM198312083092301","volume":"309","author":"A Horsman","year":"1983","unstructured":"A. Horsman, M. Jones, R. Francis, C. Nordin, The effect of estrogen dose on postmenopausal bone loss. N. Engl. J. Med. 309, 1405\u20131407 (1983)","journal-title":"N. Engl. J. Med."},{"key":"290_CR32","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1097\/01.AOG.0000117082.49490.d5","volume":"103","author":"AB Bernson","year":"2004","unstructured":"A.B. Bernson, C.R. Breitkopf, J.J. Grady, V.I. Rickert, A. Thomas, Effects of hormonal contraception on bone mineral density after 24\u00a0months of use. Obstet. Gynecol. 103, 899\u2013906 (2004)","journal-title":"Obstet. Gynecol."},{"key":"290_CR33","first-page":"967","volume":"111","author":"H Enzelsberger","year":"1989","unstructured":"H. Enzelsberger, M. Metka, G. Heytmanek, J. Huber, The effects of oral contraceptives on bone density in climacteric females. Zen Tralbl Gynakol. 111, 967\u2013973 (1989)","journal-title":"Zen Tralbl Gynakol."},{"key":"290_CR34","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0010-7824(95)00036-A","volume":"51","author":"F Polatti","year":"1995","unstructured":"F. Polatti, M. Parotti, N. Filippa, D. Gallina, R.E. Nappi, Bone mass and long-term monophasic oral contraceptive treatment in young women. Contraception 51, 221\u2013224 (1995)","journal-title":"Contraception"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-014-0290-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-014-0290-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-014-0290-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,10]],"date-time":"2019-08-10T23:54:55Z","timestamp":1565481295000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-014-0290-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,27]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["290"],"URL":"https:\/\/doi.org\/10.1007\/s12020-014-0290-2","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,27]]}}}